Witnessing the stock’s movement on the chart, on Wednesday, Soleno Therapeutics Inc (NASDAQ: SLNO) set off with pace as it heaved 2.31% to $85.52, before settling in for the price of $83.59 at the close. Taking a more long-term approach, SLNO posted a 52-week range of $41.50-$90.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 20.19% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 20.19%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 54.52%. This publicly-traded company’s shares outstanding now amounts to $48.53 million, simultaneously with a float of $43.71 million. The organization now has a market capitalization sitting at $4.51 billion. At the time of writing, stock’s 50-day Moving Average stood at $79.02, while the 200-day Moving Average is $59.77.
Soleno Therapeutics Inc (SLNO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Soleno Therapeutics Inc’s current insider ownership accounts for 17.13%, in contrast to 90.00% institutional ownership. According to the most recent insider trade that took place on Jul 01 ’25, this organization’s insider sold 3,830 shares at the rate of 82.76, making the entire transaction reach 316,971 in total value, affecting insider ownership by 13,206.
Soleno Therapeutics Inc (SLNO) Earnings and Revenue Records
Soleno Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 54.52% and is forecasted to reach 1.31 in the upcoming year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Let’s observe the current performance indicators for Soleno Therapeutics Inc (SLNO). It’s Quick Ratio in the last reported quarter now stands at 19.64.
In the same vein, SLNO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.62, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be 1.31 at the market close of one year from today.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Going through the that latest performance of [Soleno Therapeutics Inc, SLNO]. Its last 5-days volume of 2.71 million indicated improvement to the volume of 1.06 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 40.08% While, its Average True Range was 57.53%.
Raw Stochastic average of Soleno Therapeutics Inc (SLNO) in the period of the previous 100 days is set at 89.86%, which indicates a major rise in contrast to 54.80% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.35 that was higher than 3.27 volatility it exhibited in the past 100-days period.
